Tag: acquired thrombotic thrombocytopenic purpura
No posts to display
News
Merck invests over €300m in new life science research center in Germany
Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany.
In the Advanced Research Center, the...
New research centre to improve tests and treatments for rare lung diseases
A £9.4 million collaborative research centre will accelerate improved tests, treatments and potentially cures for thousands of people living with rare respiratory diseases.
The LifeArc...
Mundipharma acquires all assets and rights related to REZZAYO® (rezafungin)
Mundipharma has acquired all assets and rights related to rezafungin globally from Cidara Therapeutics.
This provides Mundipharma with global ownership of rezafungin including ongoing development...
